Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiliqiangxin in Dilated Cardiomyopathy
NCT01293903Phase 4Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- Jan 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of qiliqiangxin in dilated cardiomyopathy (DCM), sponsored by Huazhong University of Science and Technology. Started Jan 2012; status: completed.
02
Drugs
qiliqiangxin
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT01293903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01293903.